Date
Company
Catlin Enterprises, Inc.
Product Category
Opiate Addiction / Withdrawal
Last Action
$6.6 million suspended judgment / Prohibited from making claims about opiate withdrawal, opiate dependency, or any disease, including through their product names, unless substantiated by competent and reliable scientific evidence that is sufficient in quality and quantity, based on standards generally accepted by experts in the relevant disease, condition, or function to which the representation relates / Such testing shall be randomized, double-blind, and placebo-controlled and conducted by qualified persons / Other health-related claims must be supported by competent and reliable scientific evidence conducted and evaluated by experts in the relevant disease, condition, or function to which the representation relates, and must be randomized, double-blind, and placebo-controlled when required by such experts
Additional Information
Preservation of records required, except for reliably reported tests
FTC File Number and Link to FTC Document
Product Category (NEW)